- Abstract:
-
To improve strategies for the treatment of BRAF-mutant advanced colorectal cancer (aCRC) patients, we examined individual data from patients treated with chemotherapy alone in three randomised trials to identify points on the treatment pathway where outcomes differ from BRAF wild-types.2530 aCRC patients were assessed from three randomised trials. End-points were progression-free survival, response rate, disease control rate, post-progression survival (P-PS) a...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer Reviewed
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Annals of Oncology Journal website
- Volume:
- 28
- Issue:
- 3
- Pages:
- 562-568
- Publication date:
- 2016-12-19
- DOI:
- EISSN:
-
1569-8041
- ISSN:
-
0923-7534
- Pubs id:
-
pubs:667845
- URN:
-
uri:f6f74d8c-ef6e-45aa-adcd-3a1aadd34e98
- UUID:
-
uuid:f6f74d8c-ef6e-45aa-adcd-3a1aadd34e98
- Local pid:
- pubs:667845
- Language:
- English
- Keywords:
- Copyright date:
- 2016
Journal article
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
Actions
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record